CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Patient Acceptance of Semi-Inpatient Radioligand Therapy: Insights from a Prospective Survey in Nuclear Medicine
DOI 10.1055/a-2966-9616
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJonas Kaufmann, Carsten Kattinger, Stephanie Blümel, Christina Bartel, Mia Hami Glaß, Paul Martin Dahlke, Maximilian Thormann, Yasmin Ströhl, Anna Herden, Tristan Ruhwedel, Giulia Metzger, Markus Galler, Julian Manuel Michael Rogasch, Holger Amthauer, Michael Ewers, Christian Furth
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe10/2026
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Aim Radioligand therapy with lutetium-177 is an effective treatment option for patients with metastatic castration-resistant prostate cancer and metastatic neuroendocrine tumors. In Germany, radiation protection laws require hospitalization with isolation, which may cause capacity problems. Internationally, models show the feasibility of non-inpatient radioligand therapy under strict safety measures. Pati…
Zitieren
Zitierempfehlung
Jonas Kaufmann, Carsten Kattinger, Stephanie Blümel, Christina Bartel, Mia Hami Glaß, Paul Martin Dahlke, Maximilian Thormann, Yasmin Ströhl, Anna Herden, Tristan Ruhwedel, Giulia Metzger, Markus Galler, Julian Manuel Michael Rogasch, Holger Amthauer, Michael… (2026) Patient Acceptance of Semi-Inpatient Radioligand Therapy: Insights from a Prospective Survey in Nuclear Medicine. Nuklearmedizin - NuclearMedicine (10). https://doi.org/10.1055/a-2966-9616
Mit CareLit weiterarbeiten